{"id":14921,"date":"2022-10-22T19:38:58","date_gmt":"2022-10-22T19:38:58","guid":{"rendered":"http:\/\/cvx.vc\/?p=14921"},"modified":"2022-10-22T19:39:37","modified_gmt":"2022-10-22T19:39:37","slug":"dansk-biotekselskab-rejser-million-investering","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/","title":{"rendered":"Dansk biotekselskab rejser millioninvestering"},"content":{"rendered":"\n

Det dansk biotekselskab Monta Biosciences har med nye investering fra Kun\u00f8e-familien sikret sig kapital frem til udgangen af 2025. Investeringen, der tilf\u00f8jer virksomheden 84 mio. kr. i kapital fra Kun\u00f8e-familiens holdingselskab, Consolidated Bioscience.<\/p>\n\n\n\n

\u201dInvesteringen giver os en ro til at fokusere. Is\u00e6r som investeringsmarkedet er nu for biotekselskaber, er det en k\u00e6mpe bedrift og lettelse, men ogs\u00e5 tryghed, at vi har rejst denne investering nu,\u201d Udtaler adm. direkt\u00f8r og medstifter Simon Skj\u00f8de Jensen.<\/p>\n\n\n\n

Investeringen skal prim\u00e6rt bruges til at komme i m\u00e5l med virksomhedens kliniske fase 1-fors\u00f8g. Det forventes ogs\u00e5 at en del af de 84 mio. kr. skal bruges p\u00e5 at gennemf\u00f8re et fase 1b\/2a kombinations-studie.<\/p>\n\n\n\n

Monta Biosciences arbejder inden for omr\u00e5det af kr\u00e6ftimmunterapi, som aktiverer TLR7-receptoren. Virksomheden har udviklet l\u00e6gemiddelkandidaten MBS8 som Monta Biosciences lige nu tester i kliniske fors\u00f8g.<\/p>\n\n\n\n

Med den nye kapital kan Monta Biosciences udvide det klinske fase 1-fors\u00f8g og virksomheden vil \u00e5bne flere sites, hvor l\u00e6gemidlet kan testes. Det drejer sig om fire nye sites i henholdsvis Madrid og Belgien. <\/p>\n\n\n\n

\u201dFor vores investor har det v\u00e6ret ekstremt vigtigt at give os ro til at lave det, vi er bedst til, og fokusere p\u00e5 at f\u00e5 selskabet og vores asset fremad. P\u00e5 den m\u00e5de har vi ikke skulle rende rundt og snakke med investorer hele tiden for at rejse sm\u00e5 investeringer\u201d udtaler Simon Skj\u00f8de Jensen.<\/p>\n\n\n\n

L\u00e6s hele artiklen p\u00e5 KapWatch\u00a0her<\/a>.<\/a><\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.<\/p>\n","protected":false},"author":25,"featured_media":15059,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"\nDansk biotekselskab rejser millioninvestering | CVX Ventures<\/title>\n<meta name=\"description\" content=\"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dansk biotekselskab rejser millioninvestering\" \/>\n<meta property=\"og:description\" content=\"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-22T19:38:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-22T19:39:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png\" \/>\n\t<meta property=\"og:image:width\" content=\"450\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Dansk biotekselskab rejser millioninvestering\",\"datePublished\":\"2022-10-22T19:38:58+00:00\",\"dateModified\":\"2022-10-22T19:39:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\"},\"wordCount\":251,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\",\"name\":\"Dansk biotekselskab rejser millioninvestering | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png\",\"datePublished\":\"2022-10-22T19:38:58+00:00\",\"dateModified\":\"2022-10-22T19:39:37+00:00\",\"description\":\"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png\",\"width\":450,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dansk biotekselskab rejser millioninvestering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dansk biotekselskab rejser millioninvestering | CVX Ventures","description":"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/","og_locale":"da_DK","og_type":"article","og_title":"Dansk biotekselskab rejser millioninvestering","og_description":"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.","og_url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2022-10-22T19:38:58+00:00","article_modified_time":"2022-10-22T19:39:37+00:00","og_image":[{"width":450,"height":300,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png","type":"image\/png"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"2 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Dansk biotekselskab rejser millioninvestering","datePublished":"2022-10-22T19:38:58+00:00","dateModified":"2022-10-22T19:39:37+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/"},"wordCount":251,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/","url":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/","name":"Dansk biotekselskab rejser millioninvestering | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png","datePublished":"2022-10-22T19:38:58+00:00","dateModified":"2022-10-22T19:39:37+00:00","description":"Monta Biosciences har sikret sig en ny millioninvestering fra Consolidated Bioscience. Virksomheden, der arbejder med immunterapier mod kr\u00e6ft, kan nu fokusere p\u00e5 at f\u00e6rdigg\u00f8re sine fase 1-studier uden at skulle rejse yderligere kapital.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/10\/450x300-Schlosser-Thomas-8.png","width":450,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/dansk-biotekselskab-rejser-million-investering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Dansk biotekselskab rejser millioninvestering"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/14921"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=14921"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/14921\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/15059"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=14921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=14921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=14921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}